Gilead’s UC Pill Hits Trial Goal, Stock Still Slips
Gilead's ulcerative colitis trial met its main goal, but GILD shares fell 1.42% as RBC said the readout was unlikely to move the stock.
Topic
pharmaceuticals
Every Financial News story tagged pharmaceuticals, newest first.
- Stories
- 23
- Last updated
- Follow
- RSS feed
Pfizer wins FDA approval for Talzenna-Xtandi in earlier prostate cancer
Talzenna Xtandi FDA approval moves Pfizer's prostate cancer combination into earlier-stage treatment, backed by a 52% risk-reduction trial result.
CHMP backs wider dosing gap for Regeneron’s Libtayo
CHMP recommends a new Libtayo dosing regimen, cutting infusions from every three weeks to every six weeks across approved cancers.
More in pharmaceuticals
1–10 of 23
BMY’s admilparant hits IPF trial goal, but only at lower dose
Bristol Myers Squibb's admilparant Phase 3 trial met its primary endpoint in IPF, but only the 60mg dose reached significance, filings show.
Pfizer’s tilrekimig hits Phase 2 goal, moves to Phase 3 trials
Pfizer's tilrekimig Phase 2 atopic dermatitis trial hit its primary endpoint, with the drug now advancing into Phase 3 studies in two indications.
Revolution Medicines Wins FDA Pancreatic Cancer Drug Approval
The FDA's pancreatic cancer drug approval for Revolution Medicines' daraxonrasib lands months early, but the stock barely moved. Here's why.
LLY Stock Is Quietly Becoming a Giant—But Can Eli Lilly Keep Up the Momentum?
The way that people discuss LLY these days is virtually unique. Quieter tones—almost like a mutual understanding among investors that something important is happening inside Eli Lilly's labs—rather than the…
Economists Warn UK Faces Potential £22bn Export Loss with Trump’s Tariff Plans
Economists are sounding alarms over the UK potentially losing £22bn in exports. This risk arises if former US President Donald Trump implements a proposed 20% tariff on UK imports. While…
Potential £22bn Loss in UK Exports Amid Proposed US Tariffs
The prospect of a 20% tariff on UK imports to the US under Trump's trade policies alarms economists. This move poses potential threats to key sectors, including fishing and pharmaceuticals,…
MMC Research Expands to London, Driving Regional Growth
MMC Research has strategically expanded its operations to London to enhance its market reach.Alice Broomhall will spearhead the company's initiatives from their new base.The London office aims to contribute £100k…
Page 1 of 3